Merck Completes Acquisition of the Chemical Business of Mecaro
With the addition of around 100 new employees as well as state-of-the-art production and R&D facilities in Korea, Merck will expand both its regional and global capabilities
Merck announced the closing of the transaction to acquire M Chemicals Inc., the company recently incorporated by Mecaro Co. Ltd. to operate its chemical business. Combining these two businesses is expected to complement a key segment of Merck’s Semiconductor Solutions portfolio, while simultaneously building on the company’s localization efforts.
Merck KGaA
The closing of the transaction followed regulatory clearance and the fulfillment of other customary closing conditions. As a result of the acquisition, Merck will gain approximately 100 employees, as well as state-of-the-art production and R&D sites in Korea. The acquisition is part of the “Level Up” growth program of Merck’s Electronics business sector, which includes investments of significantly more than € 3 billion from 2021 to 2025 in innovation and capacities, focusing on four, mutually reinforcing key priorities: scale, technology, portfolio, as well as capabilities.
“We’re delighted to announce our recent closing of the acquisition and continue expanding our regional capabilities in Korea, as well as our overall global capacity. The acquisition of M Chemicals Inc. is another milestone in the expansion of our Electronics business and in particular Semiconductor Solutions, one of our “Big 3” growth engines, through targeted smaller to medium-sized acquisitions with high impact,” said Surésh Rajaraman, Senior Vice President and Head of Merck’s Thin Film Solutions Business Field.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
